Association between flavonoid intake and diabetes risk among the Koreans

Clinica Chimica Acta

Volumn 439, Issue , 2015, Pages 225-230

  Yeon, Jee Young ^a   Bae, Yun Jung ^b   Kim, Eun Young ^c   Lee, Eun Ju ^d  

^a National Institute of Food and Drug Safety Evaluation   (South Korea)

^b Shinhan University   (South Korea)

^c Sookmyung Women's University   (South Korea)

^d Asan Medical Center   (South Korea)

Author keywords

Flavonoid; Impaired fasting glucose; Insulin; KNHANES; Type 2 diabetes mellitus

Indexed keywords

ASCORBIC ACID; CALCIUM; CARBOHYDRATE; ERIODICTYOL; FAT; FLAVANONE; FLAVONE; FLAVONOID; FLAVONOL; GLUCOSE; HESPERETIN; INSULIN; IRON; PHOSPHORUS; PROTEIN; BLOOD GLUCOSE; FLAVONOIDS;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CRUDE FIBER; DIETARY FIBER; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT ESTIMATE OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK; RISK FACTOR; SEX DIFFERENCE; SOUTH KOREA; WAIST CIRCUMFERENCE; ANALYSIS; BLOOD; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET; DIET THERAPY; FASTING; GLUCOSE TOLERANCE TEST; HUMANS; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET; FASTING; FEMALE; FLAVONOIDS; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84930809720     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.10.042     Document Type: Article

References (44)

1. Bazzano L.A., Li T.Y., Joshipura K.J., Hu F.B. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care 2008, 31:1311-1317.
2. Song Y., Manson J.E., Buring J.E., Sesso H.D., Liu S. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J Am Coll Nutr 2005, 24:376-384.
3. Wedick N.M., Pan A., Cassidy A., et al. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr 2012, 95:925-933.
4. Bast A., Wolf G., Oberbaumer I., Walther R. Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia 2002, 45:867-876.
5. Sakuraba H., Mizukami H., Yagihashi N., Wada R., Hanyu C., Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 2002, 45:85-96.
6. Robertson R.P., Harmon J., Tran P.O., Tanaka Y., Takahashi H. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 2003, 52:581-587.
7. Bruce C.R., Carey A.L., Hawley J.A., Febbraio M.A. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 2003, 52:2338-2345.
8. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?. Diabetes 2003, 52:1-8.
9. Knekt P., Kumpulainen J., Jarvinen R., et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002, 76:560-568.
10. Hirvonen T., Pietinen P., Virtanen M., et al. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology 2001, 12:62-67.
11. Sesso H.D., Gaziano J.M., Liu S., Buring J.E. Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr 2003, 77:1400-1408.
12. Hirvonen T., Virtamo J., Korhonen P., Albanes D., Pietinen P. Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control 2001, 12:789-796.
13. Hanhineva K., Torronen R., Bondia-Pons I., et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010, 11:1365-1402.
14. Ko S.H., Kim S.R., Kim D.J., et al. 2011 clinical practice guidelines for type 2 diabetes in Korea. Diabetes Metab J 2011, 35:431-436.
15. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
16. Kang H.M., Kim D.J. Body mass index and waist circumference according to glucose tolerance status in Korea: the 2005 Korean Health and Nutrition Examination Survey. J Korean Med Sci 2012, 27:518-524.
17. Gautier A., Roussel R., Ducluzeau P.H., et al. Increases in waist circumference and weight as predictors of type 2 diabetes in individuals with impaired fasting glucose: influence of baseline BMI: data from the DESIR study. Diabetes Care 2010, 33:1850-1852.
18. Huxley R., James W.P., Barzi F., et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 2008, 9(Suppl. 1):53-61.
19. West I.C. Radicals and oxidative stress in diabetes. Diabet Med 2000, 17:171-180.
20. Gajda K., Sulich A., Hamułka J., Białkowska A. Comparing diabetic with non-diabetic overweight subjects through assessing dietary intakes and key parameters of blood biochemistry and haematology. Rocz Panstw Zakl Hig 2014, 65:133-138.
21. Yang Y.J., Kim Y.J., Yang Y.K., Kim J.Y., Kwon O. Dietary flavan-3-ols intake and metabolic syndrome risk in Korean adults. Nutr Res Pract 2012, 6:68-77.
22. Paek K.W., Chun K.H., Lee S.J. A factor of fasting blood glucose and dietary patterns in Korean adults using data from the 2007, 2008 and 2009 Korea National Health and Nutrition Examination Survey. J Prev Med Public Health 2011, 44:93-100.
23. Hollman P.C., Katan M.B. Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 1999, 37:937-942.
24. Hertog M.G., Kromhout D., Aravanis C., et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995, 155:381-386.
25. Hsu F.L., Liu I.M., Kuo D.H., Chen W.C., Su H.C., Cheng J.T. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod 2003, 66:788-792.
26. Lee Y.S., Cha B.Y., Saito K., et al. Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice. Biochem Pharmacol 2010, 79:1674-1683.
27. Anton S., Melville L., Rena G. Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin. Cell Signal 2007, 19:378-383.
28. Beking K., Vieira A. An assessment of dietary flavonoid intake in the UK and Ireland. Int J Food Sci Nutr 2011, 62:17-19.
29. Murphy M.M., Barraj L.M., Herman D., Bi X., Cheatham R., Randolph R.K. Phytonutrient intake by adults in the United States in relation to fruit and vegetable consumption. J Acad Nutr Diet 2012, 112:222-229.
30. Theodoratou E., Kyle J., Cetnarskyj R., et al. Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2007, 16:684-693.
31. Chun O.K., Chung S.J., Song W.O. Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 2007, 137:1244-1252.
32. Arai Y., Watanabe S., Kimira M., Shimoi K., Mochizuki R., Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 2000, 130:2243-2250.
33. Ovaskainen M.L., Torronen R., Koponen J.M., et al. Dietary intake and major food sources of polyphenols in Finnish adults. J Nutr 2008, 138:562-566.
34. Jung U.J., Lee M.K., Jeong K.S., Choi M.S. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J Nutr 2004, 134:2499-2503.
35. Kris-Etherton P.M., Hecker K.D., Bonanome A., et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 2002, 113(Suppl. 9B):71S-88S.
36. Chuang C.C., Martinez K., Xie G., et al. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am J Clin Nutr 2010, 92:1511-1521.
37. Stewart L.K., Soileau J.L., Ribnicky D., et al. Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Metabolism 2008, 57:S39-S46.
38. Rivera L., Moron R., Sanchez M., Zarzuelo A., Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 2008, 16:2081-2087.
39. Zhang Y., Liu D. Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur J Pharmacol 2011, 670:325-332.
40. Ricote M., Glass C.K. PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta 2007, 1771:926-935.
41. Ding L., Jin D., Chen X. Luteolin enhances insulin sensitivity via activation of PPARgamma transcriptional activity in adipocytes. J Nutr Biochem 2010, 21:941-947.
42. Stanhope K.L., Griffen S.C., Bair B.R., Swarbrick M.M., Keim N.L., Havel P.J. Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. Am J Clin Nutr 2008, 87:1194-1203.
43. Livesey G., Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr 2008, 88:1419-1437.
44. Livesey G. Fructose ingestion: dose-dependent responses in health research. J Nutr 2009, 139:1246S-1252S.